These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27855770)

  • 1. [Epidemic increase in the incidence of carbapenemase-producing Enterobacteriaceae in Denmark].
    Wang M; Ellermann-Eriksen S; Hansen DS; Kjerulf A; Fuglsang-Damgaard D; Holm A; Østergaard C; Røder B; Sönksen UW; Detlefsen M; Hansen F; Hasman H; Hammerum A; Skov RL
    Ugeskr Laeger; 2016 Nov; 178(45):. PubMed ID: 27855770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of Carbapenemase-Producing Enterobacteriaceae, South-Central Ontario, Canada
    Kohler PP; Melano RG; Patel SN; Shafinaz S; Faheem A; Coleman BL; Green K; Armstrong I; Almohri H; Borgia S; Borgundvaag E; Johnstone J; Katz K; Lam F; Muller MP; Powis J; Poutanen SM; Richardson D; Rebbapragada A; Sarabia A; Simor A; McGeer A;
    Emerg Infect Dis; 2018 Sep; 24(9):1674-1682. PubMed ID: 30124197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
    Tängdén T; Giske CG
    J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbapenemase-producing Enterobacteriaceae in the UK: a national study (EuSCAPE-UK) on prevalence, incidence, laboratory detection methods and infection control measures.
    Trepanier P; Mallard K; Meunier D; Pike R; Brown D; Ashby JP; Donaldson H; Awad-El-Kariem FM; Balakrishnan I; Cubbon M; Chadwick PR; Doughton M; Doughton R; Hardiman F; Harvey G; Horner C; Lee J; Lewis J; Loughrey A; Manuel R; Parsons H; Perry JD; Vanstone G; White G; Shetty N; Coia J; Wiuff C; Hopkins KL; Woodford N
    J Antimicrob Chemother; 2017 Feb; 72(2):596-603. PubMed ID: 27687074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control strategy for carbapenemase-producing Enterobacteriaceae in nursing homes: perspectives inspired from three outbreaks.
    Legeay C; Hue R; Berton C; Cormier H; Chenouard R; Corvec S; Birgand G
    J Hosp Infect; 2019 Feb; 101(2):183-187. PubMed ID: 30389597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing Enterobacteriaceae and its effect on CPE infections.
    Smolders D; Hendriks B; Rogiers P; Mul M; Gordts B
    J Hosp Infect; 2019 May; 102(1):82-88. PubMed ID: 30579969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018.
    Brolund A; Lagerqvist N; Byfors S; Struelens MJ; Monnet DL; Albiger B; Kohlenberg A;
    Euro Surveill; 2019 Feb; 24(9):. PubMed ID: 30862330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
    Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
    Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenemase-producing Enterobacteriaceae in Finland: the first years (2008-11).
    Österblad M; Kirveskari J; Hakanen AJ; Tissari P; Vaara M; Jalava J
    J Antimicrob Chemother; 2012 Dec; 67(12):2860-4. PubMed ID: 22855858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan.
    Blakiston M; Heffernan H; Roberts S; Freeman J
    N Z Med J; 2017 Apr; 130(1454):72-79. PubMed ID: 28449019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of meticillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae in Danish emergency departments - evaluation of national screening guidelines.
    Skjøt-Arkil H; Mogensen CB; Lassen AT; Johansen IS; Chen M; Petersen P; Andersen KV; Ellermann-Eriksen S; Møller JM; Ludwig M; Fuglsang-Damgaard D; Nielsen FE; Petersen DB; Jensen US; Rosenvinge FS
    J Hosp Infect; 2020 Jan; 104(1):27-32. PubMed ID: 31494129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
    Legeay C; Thépot-Seegers V; Pailhoriès H; Hilliquin D; Zahar JR
    J Hosp Infect; 2018 Aug; 99(4):390-395. PubMed ID: 29438727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014.
    Samuelsen Ø; Overballe-Petersen S; Bjørnholt JV; Brisse S; Doumith M; Woodford N; Hopkins KL; Aasnæs B; Haldorsen B; Sundsfjord A;
    PLoS One; 2017; 12(11):e0187832. PubMed ID: 29141051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The global epidemiology of carbapenemase-producing Enterobacteriaceae.
    van Duin D; Doi Y
    Virulence; 2017 May; 8(4):460-469. PubMed ID: 27593176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain.
    García-Castillo M; García-Fernández S; Gómez-Gil R; Pitart C; Oviaño M; Gracia-Ahufinger I; Díaz-Regañón J; Tato M; Cantón R;
    Int J Antimicrob Agents; 2018 Mar; 51(3):511-515. PubMed ID: 29371104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colonization with extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacteriaceae in international travelers returning to Germany.
    Lübbert C; Straube L; Stein C; Makarewicz O; Schubert S; Mössner J; Pletz MW; Rodloff AC
    Int J Med Microbiol; 2015 Jan; 305(1):148-56. PubMed ID: 25547265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.